Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
$96.32−2.92 (-2.94%)
Close on Nov 17, 2026Market cap $6.38BP/E –Yield –
Oruka Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oruka Therapeutics's enterprise value was $5.67B on Nov 11, 2026, against $1.11B a year earlier. Over the last 5 years it ranged from $4.37M to $5.67B, with a median of $340.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.67B | +407.6% |
| 2025 | Dec 31, 2025 | $1.12B | +317.3% |
| 2024 | Dec 31, 2024 | $267.75M | +4.8% |
| 2023 | Dec 29, 2023 | $255.49M | -30.2% |
| 2022 | Dec 30, 2022 | $365.90M | +16.7% |
| 2021 | Dec 31, 2021 | $313.48M | -20.8% |
| 2020 | Dec 31, 2020 | $395.75M | +297.3% |
| 2019 | Dec 31, 2019 | $99.60M | +111.5% |
| 2018 | Dec 31, 2018 | $47.08M | -73.0% |
| 2017 | Dec 29, 2017 | $174.40M | -39.2% |
| 2016 | Dec 30, 2016 | $287.08M | -38.1% |
| 2015 | Dec 31, 2015 | $463.50M | +107.1% |
| 2014 | Dec 31, 2014 | $223.75M | -9.6% |
| 2013 | Dec 31, 2013 | $247.39M | +372.4% |
| 2012 | Dec 31, 2012 | $52.37M | -56.5% |
| 2011 | Dec 30, 2011 | $120.44M | – |
See a number that looks wrong?